Multicomponent reactions (MCRs) are important processes, in which more than three different reactants directly get converted into one new structure bearing most of the atoms of these reactants. It is a very powerful tool in drug discovery and combinational chemistry. A new pseudo‐four‐component synthetic approach to 5‐(5‐hydroxy‐3‐methyl‐1H‐pyrazol‐4‐yl)‐substituted 5H‐chromeno[2,3‐b]pyridines with 68%–95% yields is reported. This MCR opens an efficient and convenient way to substituted 5H‐chromeno[2,3‐b]pyridines, which are promising compounds in medicinal chemistry and for the treatment of lung cancer through inhibition of aldo‐keto reductase 1B10. A new consensus approach of molecular docking and molecular dynamics was applied for the investigation of interaction of synthesized 5H‐chromeno[2,3‐b]pyridines and aldo‐keto reductase 1B10.